Lucentis: Another Shot in the Eye, Effective TX for ARMD

Lucentis™ is the second intraocular, anti-VEGF injection FDA approved for the treatment of wet macular degeneration.  It was approved in 2006.  It fast became the mainstay of the treatment for wet macular degeneration.  It is still popular today among retina specialists for treatment of wet macular degeneration. Facts About Lucentis FDA approved for the … [Read more...]

Eye Injections Challenge Eye Laser for Diabetic Retinopathy

There is a small study just published in the journal "Ophthalmology" stating that intraocular injections of Lucentis® were superior to laser photocoagulation for the treatment of diabetic macular edema.  As you read this, don't forget that the "gold-standard" for treatment of diabetic macular edema is still laser photocoagulation.  These "studies" are very small and not … [Read more...]

SurModics’ Drug Delivery to Release Lucentis for Macular Degeneration

In a press release this week, Surmodics, Inc., announced its agreement with Roche and Genentech, manufactureres of Lucentis® (ranibizumab), to develop a sustained release drug delivery system for the treatment of wet macular degeneration. Surmodics has a drug delivery system based upon biodegradable microparticles that may potentially reduce the annual number … [Read more...]

Diabetic Retinopathy Vs. Macular Degeneration (Part 2 of 2)

Good Morning!  This is part 2 of 2.  Part 1 was posted yesterday.  Read Part 1. 6.  Treatment with Avastin® or other anti-VEGF inhibitors Technically, both diseases may be treated with anti-VEGF inhibitors. Presently, I sometimes treat the neovascular component of diabetic retinopathy with Avastin® if pan-retinal laser photocoagulation (standard treatment) … [Read more...]

Diabetics Get Cataracts

Cataracts are like grey hair..............everyone gets cataracts, some at an early age and some at a later age.  Period. Cataracts are generally not inherited (okay, there are some inherited or congenital cataracts seen in kids).  There are many factors that may influence the development of a cataract; ultraviolet rays from the sun, trauma, previous eye surgery and … [Read more...]

Retinal Vein Occlusions – New Hope on the Horizon

There are two types of retinal vein occlusions (RVO), branch retinal vein occlusions (BRVO) and central retinal vein occlusion (CRVO). In both of these scenarios, the central vein that drains blood from the retina becomes occluded partially (as in the case of BRVO) or completely (as in the case of CRVO). The mainstay of treatment for either has been treatment with an … [Read more...]

Cases of ARMD to Double

In this month's (April,  2009) edition of Archives of Ophthalmology, a study reports the prevalence of patients afflicted with macular degeneration is expected to almost double by the year 2050.  In other words, the number of patients suffering the disease at a given time is expected to near double in the next 40 years. All forms of macular degeneration are expected … [Read more...]

Privacy Policy · Terms of Use
Web Strategy by Medical Marketing Enterprises, LLC